{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T18:48:53Z","timestamp":1794336533185,"version":"4.9.0"},"publisher-location":"Berlin, Heidelberg","reference-count":141,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"value":"9783540225690","type":"print"},{"value":"9783540276616","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005]]},"DOI":"10.1007\/3-540-27661-0_22","type":"book-chapter","created":{"date-parts":[[2005,11,2]],"date-time":"2005-11-02T16:06:13Z","timestamp":1130947573000},"page":"591-617","source":"Crossref","is-referenced-by-count":2,"title":["Correction of Insulin Resistance and the Metabolic Syndrome"],"prefix":"10.1007","author":[{"given":"D.","family":"M\u00fcller-Wieland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Kotzka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"22_CR1","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1172\/JCI1594","volume":"101","author":"H. Abe","year":"1998","unstructured":"Abe H, Yamada N, Kamata K, et al. (1998)Hypertension, hypertriglyceridemia and impaired endothelium-dependent vascular relaxation in mice lacking insulin receptor substrate-1. J Clin Invest 101:1784\u20131788","journal-title":"J Clin Invest"},{"key":"22_CR2","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.2337\/diabetes.53.7.1633","volume":"53","author":"D. Accili","year":"2004","unstructured":"Accili D (2004) The struggle for mastery in insulin action: from triumvirate to republic. Diabetes 53:1633\u20131642","journal-title":"Diabetes"},{"key":"22_CR3","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/ng0196-106","volume":"12","author":"D. Accili","year":"1996","unstructured":"Accili D, Drago J, Lee EJ, Johnson MD, et al. (1996) Early neonatal death in mice homozygous for a null allele of the insulin receptor gene. Nature Genet 12:106\u2013109","journal-title":"Nature Genet"},{"key":"22_CR4","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1074\/jbc.M101521200","volume":"277","author":"V. Aguirre","year":"2002","unstructured":"Aguirre V, Werner ED, Giraud J, et al. (2002) Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action. J Biol Chem 277:1531\u20131537","journal-title":"J Biol Chem"},{"key":"22_CR5","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.2337\/diabetes.52.5.1210","volume":"52","author":"C.M. Alexander","year":"2003","unstructured":"Alexander CM, Landsman PB, Teutsch SM, et al. (2003) NCEP-defined metabolic syndrome, diabetes, and prevalence coronary heart disease among NHANES III participants age 50 years and older. Diabetes 52:1210\u20131214","journal-title":"Diabetes"},{"key":"22_CR6","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0014-5793(96)01342-7","volume":"400","author":"H. Al-Hasani","year":"1997","unstructured":"Al-Hasani H, Eisermann B, Tennagels N, et al. (1997) Identification of Ser-1275 and Ser-1309 as autophosphorylation sites of the insulin receptor. FEBS 400:65\u201370","journal-title":"FEBS"},{"key":"22_CR7","doi-asserted-by":"publisher","first-page":"H414","DOI":"10.1152\/ajpheart.01046.2003","volume":"287","author":"G.E. Alvarez","year":"2004","unstructured":"Alvarez GE, Ballard TP, Beske SD, Davy KP (2004) Subcutaneous obesity is not associated with sympathetic neural activation. Am J Physiol Heart Circ Physiol 287:H414\u2013H418","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"22_CR8","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/nm995","volume":"10","author":"J. An","year":"2004","unstructured":"An J, Muoio DM, Shiota M, et al. (2004) Hepatic expression of malonyl-CoA decarboxylase reverses muscle, liver and whole-animal insulin resistance. Nature Med 10:268\u2013274","journal-title":"Nature Med"},{"key":"22_CR9","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/372186a0","volume":"372","author":"E. Araki","year":"1994","unstructured":"Araki E, Lipes MA, Patti ME, et al. (1994) Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature 372:186\u2013190","journal-title":"Nature"},{"key":"22_CR10","volume-title":"Pr\u00e4vention der koronaren Herzkrankheit","author":"G. Assmann","year":"2003","unstructured":"Assmann G, Buyken A, Cullen P, et al. (2003) Pr\u00e4vention der koronaren Herzkrankheit. 1st Edn. Bruckmeier Verlag GmbH, Gr\u00fcnwald","edition":"1st Edn."},{"key":"22_CR11","first-page":"21","volume-title":"Atherosclerosis XII","author":"J. Auwerx","year":"2000","unstructured":"Auwerx J, Mangelsdorf D (2000) X-ceptors, nuclear receptors for metabolism. In: Stemme S, Olsson AG (eds) Atherosclerosis XII. Elsevier Science BV, Amsterdam, pp 21\u201339"},{"key":"22_CR12","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1023\/A:1006823109415","volume":"182","author":"J. Avruch","year":"1998","unstructured":"Avruch J (1998) Insulin signal transduction through protein kinase cascades. Mol Cell Biochem 182:31\u201348","journal-title":"Mol Cell Biochem"},{"key":"22_CR13","first-page":"953","volume-title":"International textbook of diabetes mellitus","author":"C.J. Bailey","year":"2004","unstructured":"Bailey CJ (2004) New Drugs for the Treatment of Diabetes Mellitus. In: DeFronzo RA, Ferrannini E, Keen H, Zimmet P (eds) International textbook of diabetes mellitus, 3rd Edn. John Wiley & Sons Ltd, Chichester pp 953\u2013979","edition":"3rd Edn."},{"key":"22_CR14","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.1210\/en.2003-1608","volume":"145","author":"R.S. Bains","year":"2004","unstructured":"Bains RS, Wells SE, Flavell DM, et al. (2004) Visceral obesity without insulin resistance in late-onset obesity rats. Endocrinology 145:2666\u20132679","journal-title":"Endocrinology"},{"key":"22_CR15","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S1534-5807(02)00199-5","volume":"3","author":"M. Bluher","year":"2002","unstructured":"Bluher M, Michael MD, Perone OD, et al. (2002) Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance. Dev Cell 3:25\u201338","journal-title":"Dev Cell"},{"issue":"Suppl. 3","key":"22_CR16","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1046\/j.1365-2362.32.s3.3.x","volume":"32","author":"G. Boden","year":"2002","unstructured":"Boden G, Shulman GI (2002) Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction. Eur J Clin Invest 32(Suppl. 3):14\u201323","journal-title":"Eur J Clin Invest"},{"key":"22_CR17","doi-asserted-by":"crossref","first-page":"14490","DOI":"10.1016\/S0021-9258(19)85265-1","volume":"268","author":"M.R. Briggs","year":"1993","unstructured":"Briggs MR, Yokoyama C, Wang X, Brown MS, Goldstein JL (1993) Nuclear protein that binds sterol regulatory element of low density lipoprotein receptor promoter. I. Identification of the protein and delineation of its target nucleotide sequence. J Biol Chem 268:14490\u201314496","journal-title":"J Biol Chem"},{"key":"22_CR18","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0092-8674(00)80213-5","volume":"89","author":"M.S. Brown","year":"1997","unstructured":"Brown MS, Goldstein JL (1997) The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 89:331\u2013320","journal-title":"Cell"},{"key":"22_CR19","doi-asserted-by":"publisher","first-page":"11041","DOI":"10.1073\/pnas.96.20.11041","volume":"96","author":"M.S. Brown","year":"1999","unstructured":"Brown MS, Goldstein JL (1999) A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood. Proc Natl Acad Sci USA 96:11041\u201311048","journal-title":"Proc Natl Acad Sci USA"},{"key":"22_CR20","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/S0092-8674(00)81896-6","volume":"88","author":"J.C. Bruning","year":"1997","unstructured":"Bruning JC, Winnay J, Bonner-Weir S, et al. (1997) Development of a novel polygenic model of NIDDM in mice heterozygous for IR and IRS-1 null alleles. Cell 88:561\u2013572","journal-title":"Cell"},{"key":"22_CR21","first-page":"2122","volume":"299","author":"J.C. Bruning","year":"1998","unstructured":"Bruning JC, Gautam D, Burks DJ, et al. (1998a) Role of the brain insulin receptor in control of body weight and reproduction. Science 299:2122\u20132125","journal-title":"Science"},{"key":"22_CR22","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/S1097-2765(00)80155-0","volume":"2","author":"J.C. Bruning","year":"1998","unstructured":"Bruning JC, Michael MD, Winnay JN, et al. (1998b) A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol Cell 2:559\u2013569","journal-title":"Mol Cell"},{"key":"22_CR23","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.2337\/diabetes.51.9.2796","volume":"51","author":"T.A. Buchanan","year":"2002","unstructured":"Buchanan TA, Xiang AH, Peters RK, et al. (2002) Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women. Diabetes 51:2796\u20132803","journal-title":"Diabetes"},{"key":"22_CR24","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S1262-3636(07)70112-X","volume":"30","author":"R. Cancello","year":"2004","unstructured":"Cancello R, Tounian A, Poitou Ch, Cl\u00e9ment K (2004) Adiposity signals, genetic and body weight regulation in humans. Diabetes Metab 30:215\u2013227","journal-title":"Diabetes Metab"},{"key":"22_CR25","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1097\/00002030-200311210-00005","volume":"17","author":"M. Caron","year":"2003","unstructured":"Caron M, Auclair M, Sterlingot H, et al. (2003) Some HIV protease inhibitors alter lamin A\/C maturation and stability, SREBP-1 nuclear localization and adipocyte differentiation. AIDS 17:2437\u20132444","journal-title":"AIDS"},{"key":"22_CR26","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1016\/S0140-6736(02)08905-5","volume":"359","author":"J.L. Chiasson","year":"2002","unstructured":"Chiasson JL, Josse RG, Gomis R, et al. (2002) Acarbose for prevention of type 2 diabetes mellitus: the STOPP-NIDDM randomized trial. Lancet 359:2072\u20132077","journal-title":"Lancet"},{"key":"22_CR27","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1001\/jama.290.4.486","volume":"290","author":"J.L. Chiasson","year":"2003","unstructured":"Chiasson JL, Josse RG, Gomis R, et al. (2003) Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOPP-NIDDM trial. JAMA 290:486\u2013494","journal-title":"JAMA"},{"key":"22_CR28","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.bbrc.2003.11.160","volume":"313","author":"L. Duplomb","year":"2004","unstructured":"Duplomb L, Lee Y, Wang MY, et al. (2004) Increased expression and activity of 11beta-HSD-1 in diabetic islets and prevention with troglitazone. Biochem Biophys Res Commun 313:594\u2013599","journal-title":"Biochem Biophys Res Commun"},{"key":"22_CR29","doi-asserted-by":"crossref","first-page":"3760","DOI":"10.1128\/MCB.19.5.3760","volume":"19","author":"M. Foretz","year":"1999","unstructured":"Foretz M, Pacot C, Dugail I, et al. (1999a) ADD1\/SREBP-1c is required in the activation of hepatic lipogenic gene expression by glucose. Mol Cell Biol 19:3760\u20133768","journal-title":"Mol Cell Biol"},{"key":"22_CR30","doi-asserted-by":"publisher","first-page":"12737","DOI":"10.1073\/pnas.96.22.12737","volume":"96","author":"M. Foretz","year":"1999","unstructured":"Foretz M, Guichard C, Ferre P, Foufelle F (1999b) Sterol regulatory element binding protein-1c is a major mediator of insulin action on the hepatic expression of glucokinase and lipogenesis-related genes. Proc Natl Acad Sci USA 96:12737\u201312742","journal-title":"Proc Natl Acad Sci USA"},{"key":"22_CR31","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.1210\/en.2003-1671","volume":"145","author":"L. Fu","year":"2004","unstructured":"Fu L, John ML, Adams SH, et al. (2004) Fibroblast growth factor 19 increases metabolic rate and reverses dietary and leptin-deficient diabetes. Endocrinology 145:2594\u20132603","journal-title":"Endocrinology"},{"key":"22_CR32","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1210\/jc.2003-031507","volume":"89","author":"V. Giusti","year":"2004","unstructured":"Giusti V, Suter M, Verdumo C, et al. (2004) Molecular determinants of human adipose tissue: differences between visceral and subcutaneous compartments in obese women. J Clin Endocrinol Metab 89:1379\u20131384","journal-title":"J Clin Endocrinol Metab"},{"key":"22_CR33","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1210\/jc.87.6.2474","volume":"87","author":"B.J. Goldstein","year":"2002","unstructured":"Goldstein BJ (2002a) Protein-tyrosine phosphatases: emerging targets for therapeutic intervention in type 2 diabetes and related states of insulin resistance. J Clin Endocrinol Metab 87:2472\u20132480","journal-title":"J Clin Endocrinol Metab"},{"key":"22_CR34","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1016\/S0149-2918(02)80040-6","volume":"24","author":"B.J. Goldstein","year":"2002","unstructured":"Goldstein BJ (2002b) Possible vascular-protective effects of antidiabetic agents such as the thiazolidinediones (TZDs). Clin Ther 24:1358\u20131360","journal-title":"Clin Ther"},{"key":"22_CR35","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1161\/01.CIR.0000111245.75752.C6","volume":"109","author":"S.M. Grundy","year":"2004","unstructured":"Grundy SM, Brewer HG, Cleeman JI, et al. for the conference participants (2004a) Definition of metabolic syndrome. Report of the National Heart, Lung, and Blood Institute\/American Heart Association Conference on Scientific Issues Related to Definition. Circulation 109:433\u2013438","journal-title":"Circulation"},{"key":"22_CR36","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1161\/01.CIR.0000112379.88385.67","volume":"209","author":"S.M. Grundy","year":"2004","unstructured":"Grundy SM, Hansen B, Smith SC, et al. for the conference participants (2004b) Clinical management of metabolic syndrome. Report of the American Heart Association\/National Heart, Lung, and Blood Institute\/American Diabetes Association Conference on Scientific Issues Related to Management. Circulation 209:551\u2013556","journal-title":"Circulation"},{"key":"22_CR37","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S1262-3636(07)70084-8","volume":"30","author":"M. Guerre-Millo","year":"2004","unstructured":"Guerre-Millo M (2004) Adipose tissue and adipokines: for better or worse. Diabetes Metab 30:13\u201319","journal-title":"Diabetes Metab"},{"key":"22_CR38","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1111\/j.1440-1746.2004.03312.x","volume":"19","author":"P. Gupte","year":"2004","unstructured":"Gupte P, Amarapurkar D, Agal S, et al. (2004) Non-alcoholic steatohepatitis in type 2 diabetes mellitus. J Gastroenterol Hepatol 19:854\u2013858","journal-title":"J Gastroenterol Hepatol"},{"key":"22_CR39","doi-asserted-by":"publisher","first-page":"15130","DOI":"10.1074\/jbc.M312875200","volume":"279","author":"K.E. Hadri","year":"2004","unstructured":"Hadri KE, Glorian M, Monsempes C, et al. (2004) In vitro suppression of the lipogenic pathway by the nonnucleoside reverse transcriptase inhibitor efavirenz in 3T and human preadipocytes or adipocytes. J Biol Chem 279:15130\u201315141","journal-title":"J Biol Chem"},{"key":"22_CR40","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/35093131","volume":"413","author":"S. Herzig","year":"2001","unstructured":"Herzig S, Long F, Jhala US, et al. (2001) CREB regulates hepatic gluconeogenesis through the coactivator PGC-1. Nature 413:179\u2013183","journal-title":"Nature"},{"key":"22_CR41","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1172\/JCI0215593","volume":"109","author":"J.D. Horton","year":"2002","unstructured":"Horton JD, Goldstein JL, Brown MS (2002) SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest 109:1125\u20131131","journal-title":"J Clin Invest"},{"key":"22_CR42","doi-asserted-by":"publisher","first-page":"36652","DOI":"10.1074\/jbc.M306540200","volume":"278","author":"J.D. Horton","year":"2003","unstructured":"Horton JD, Shimomura I, Ikemoto S, et al. (2003) Overexpression of SREBP-1a in mouse adipose tissue produces adipocyte hypertrophy, increased fatty acid secretion, and fatty liver. J Biol Chem 278:36652\u201336660","journal-title":"J Biol Chem"},{"key":"22_CR43","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.2337\/diabetes.51.10.2959","volume":"51","author":"J.A. Houmard","year":"2002","unstructured":"Houmard JA, Tanner CJ, Yu C, et al. (2002) Effect of weight loss on insulin sensitivity and intramuscular long-chain fatty acyl-CoAs in morbidly obese subjects. Diabetes 51:2959\u20132963","journal-title":"Diabetes"},{"key":"22_CR44","doi-asserted-by":"crossref","first-page":"11603","DOI":"10.1073\/pnas.90.24.11603","volume":"90","author":"X. Hua","year":"1993","unstructured":"Hua X, Yokoyama C, Wu J, et al. (1993) SREBP-2, a second basic-helix-loop-helix-leucine zipper protein that stimulates transcription by binding to a sterol regulatory element. Proc Natl Acad Sci USA 90:11603\u201311607","journal-title":"Proc Natl Acad Sci USA"},{"key":"22_CR45","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/0888-7543(95)80009-B","volume":"10","author":"X. Hua","year":"1995","unstructured":"Hua X, Wu J, Goldstein JL, Brown MS, Hobbs HH (1995) Structure of the human gene encoding sterol regulatory element binding protein-1 (SREBF1) and localization of SREBF1 and SREBF2 to chromosomes 17p11.2 and 22q13. Genomics 10:667\u2013673","journal-title":"Genomics"},{"key":"22_CR46","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/hep.20280","volume":"40","author":"J.M. Hui","year":"2004","unstructured":"Hui JM, Hodge A, Farrell GC, et al. (2004) Beyond insulin resistance in NASH: TNF-alpha or adiponectin. Hepatology 40:46\u201354","journal-title":"Hepatology"},{"key":"22_CR47","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1172\/JCI200214955","volume":"109","author":"R.S. Hundal","year":"2002","unstructured":"Hundal RS, Petersen KF, Mayerson AB, et al. (2002) Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes. J Clin Invest 109:1321\u20131326","journal-title":"J Clin Invest"},{"key":"22_CR48","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1749-6632.2002.tb04261.x","volume":"967","author":"K. Hyoun-Ju","year":"2002","unstructured":"Hyoun-Ju K, Miyazaki M, Man WC, et al. (2002) Sterol regulatory element-binding proteins (SREBPs) as regulators of lipid metabolism. Polyunsaturated fatty acids oppose cholesterols-mediated induction of SREBP-1 maturation. Ann NY Acad Sci 967:34\u201342","journal-title":"Ann NY Acad Sci"},{"key":"22_CR49","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/ncb1111","volume":"6","author":"T. Ide","year":"2004","unstructured":"Ide T, Shimano H, Yahagi N, et al. (2004) SREBPs suppress IRS-2-mediated insulin signaling in the liver. Nat Cell Biol 6:351\u2013357","journal-title":"Nat Cell Biol"},{"key":"22_CR50","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.2337\/diabetes.48.5.1113","volume":"48","author":"S. Jacob","year":"1999","unstructured":"Jacob S, Machann J, Rett K, et al. (1999) Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects. Diabetes 48:1113\u20131119","journal-title":"Diabetes"},{"key":"22_CR51","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1002\/j.1460-2075.1996.tb00498.x","volume":"15","author":"R.L. Joshi","year":"1996","unstructured":"Joshi RL, Lamothe B, Cordonnier N, et al. (1996) Targeted disruption of the insulin receptor gene in the mouse results in neonatal lethality. EMBO J 15:1542\u20131547","journal-title":"EMBO J"},{"key":"22_CR52","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1016\/S0140-6736(04)16451-9","volume":"363","author":"S. Julius","year":"2004","unstructured":"Julius S, Kjeldsen SE, Weber M (2004) Outcomes in hypertensive patients at high cardiovascular risk treated with regimes based on valsartan or amlodipine: the VALUE randomised trial. Lancet 363:2022\u20132031","journal-title":"Lancet"},{"key":"22_CR53","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1172\/JCI10830","volume":"106","author":"T. Kadowaki","year":"2000","unstructured":"Kadowaki T (2000) Insights into insulin resistance and type 2 diabetes from knockout mouse models. J Clin Invest 106:459\u2013465","journal-title":"J Clin Invest"},{"key":"22_CR54","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1097\/00002030-200308150-00004","volume":"17","author":"K. Kannisto","year":"2003","unstructured":"Kannisto K, Sutinen J, Korsheninnikova E, et al. (2003) Expression of adipogenic transcription factors, peroxisome proliferation-activated receptor gamma co-activator 1, IL-6 and CD45 in subcutaneous adipose tissue in lipodystrophy association with highly active antiretroviral therapy. AIDS 17:1753\u20131762","journal-title":"AIDS"},{"key":"22_CR55","first-page":"933","volume":"24","author":"D.E. Kelley","year":"2001","unstructured":"Kelley DE, Goodpaster BH (2001) Skeletal muscle triglyceride. an aspect of regional adiposity and insulin resistance. Diabetes 24:933\u2013941","journal-title":"Diabetes"},{"key":"22_CR56","doi-asserted-by":"crossref","first-page":"8456","DOI":"10.1074\/jbc.275.12.8456","volume":"276","author":"J.K. Kim","year":"2000","unstructured":"Kim JK, Gavrilova O, Chen Y, et al. (2000) Mechanisms of insulin resistance in A-ZIP\/17-1 fatless mice. Biol Chem 276:8456\u20138460","journal-title":"Biol Chem"},{"key":"22_CR57","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1172\/JCI8305","volume":"105","author":"J.K. Kim","year":"2000","unstructured":"Kim JK, Michael MD, Previs SF, et al. (2000a) Redistribution of substrates to adipose tissue promotes obesity in mice with selective insulin resistance in muscle. J Clin Invest 105:1791\u20131797","journal-title":"J Clin Invest"},{"key":"22_CR58","doi-asserted-by":"crossref","first-page":"32915","DOI":"10.1074\/jbc.M204710200","volume":"277","author":"Y.B. Kim","year":"2002","unstructured":"Kim YB, Shulman GI, Kahn BB (2002b) Fatty acid infusion selectively impairs insulin action on Akt1 and protein kinase C lambda\/zeta but not on glycogen synthase kinase-3. J Biol Chem 277:32915\u201332922","journal-title":"J Biol Chem"},{"key":"22_CR59","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1172\/JCI200418917","volume":"113","author":"J.K. Kim","year":"2004","unstructured":"Kim JK, Gimeno RE, Higashimori, et al. (2004) Inactivation of fatty acid transport protein 1 prevents fat-induaced insulin resistance in skeletal muscle. J Clin Invest 113:756\u2013763","journal-title":"J Clin Invest"},{"key":"22_CR60","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1056\/NEJMoa033179","volume":"350","author":"S. Klein","year":"2004","unstructured":"Klein S, Fontana L, Young L, et al. (2004) Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease. N Engl J Med 350:2549\u20132557","journal-title":"N Engl J Med"},{"key":"22_CR61","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","volume":"346","author":"W.C. Knowler","year":"2002","unstructured":"Knowler WC, Barrett-Connor E, Fowler SE, et al. (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393\u2013403","journal-title":"N Engl J Med"},{"key":"22_CR62","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1006\/bbrc.1998.9161","volume":"249","author":"J. Kotzka","year":"1998","unstructured":"Kotzka J, Muller-Wieland D, Koponen A, et al. (1998) ADD1\/SREBP-1c mediates insulin-induced gene expression linked to the MAP kinase pathway. Biochem Biophys Res Commun 249:375\u2013379","journal-title":"Biochem Biophys Res Commun"},{"key":"22_CR63","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0022-2275(20)32079-4","volume":"41","author":"J. Kotzka","year":"2000","unstructured":"Kotzka J, Muller-Wieland D, Roth G, et al. (2000) Sterol regulatory element binding proteins SREBP-1a and SREBP-2 are linked to the map kinase cascade. J Lipid Res 41:99\u2013108","journal-title":"J Lipid Res"},{"key":"22_CR64","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1517\/14728222.8.2.141","volume":"8","author":"J. Kotzka","year":"2004","unstructured":"Kotzka J, M\u00fcller-Wieland D (2004) Sterol regulatory element-binding protein (SREBP)-1: gene regulatory target for insulin resistance? Expert Opin Ther Targets 8:141\u2013149","journal-title":"Expert Opin Ther Targets"},{"key":"22_CR65","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.2337\/diabetes.49.11.1880","volume":"49","author":"N. Kubota","year":"2000","unstructured":"Kubota N, Tobe K, Terauchi Y, et al. (2000) Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory \u00df-cell hyperplasia. Diabetes 49:1880\u20131889","journal-title":"Diabetes"},{"key":"22_CR66","doi-asserted-by":"crossref","first-page":"R67","DOI":"10.1172\/JCI8339","volume":"104","author":"R.N. Kulkarni","year":"1999","unstructured":"Kulkarni RN, Winnay JN, Daniels M, et al. (1999a) Altered function of insulin receptor substrate 1-deficientmouse islets and cultured beta-cell lines. J Clin Invest 104:R67\u2013R75","journal-title":"J Clin Invest"},{"key":"22_CR67","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0092-8674(00)80546-2","volume":"96","author":"R.N. Kulkarni","year":"1999","unstructured":"Kulkarni RN, Bruning JC, Winnay JN, et al. (1999b) Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell 96:329\u2013339","journal-title":"Cell"},{"key":"22_CR68","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/S0140-6736(46)90528-4","volume":"1","author":"R.D. Lawrence","year":"1946","unstructured":"Lawrence RD (1946) Lypodystrophy and hepatomegaly with diabetes, lipaemia and other metabolic disturbances. A case throwing new light on the action of insulin. Lancet 1:724\u2013731","journal-title":"Lancet"},{"key":"22_CR69","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/BF02980074","volume":"27","author":"Y.H. Lee","year":"2004","unstructured":"Lee YH, White MF (2004) Insulin receptor substrate proteins and diabetes. Arch Pharm Res 27:361\u2013370","journal-title":"Arch Pharm Res"},{"key":"22_CR70","doi-asserted-by":"crossref","first-page":"10898","DOI":"10.1021\/bi000982k","volume":"49","author":"S. Lehr","year":"2000","unstructured":"Lehr S, Kotzka J, Herkner A, et al. (2000) Identification of major tyrosine phosphorylation sites in the human insulin receptor substrate Gab-1 by insulin receptor kinase in vitro. Biochemistry 49:10898\u201310907","journal-title":"Biochemistry"},{"key":"22_CR71","doi-asserted-by":"crossref","unstructured":"Lehr S, Kotzka J, Avci H, et al. (2004a) Effect of SREBP-1a on intracellular lipids and mitochondrial protein pattern in human liver cells detected by 2D-DIGE. Biochemistry (in press)","DOI":"10.1021\/bi0479656"},{"key":"22_CR72","doi-asserted-by":"publisher","first-page":"12133","DOI":"10.1021\/bi049753e","volume":"43","author":"S. Lehr","year":"2004","unstructured":"Lehr S, Kotzka J, Avci H, et al. (2004b) Identification of Major ERK-Related Phosphorylation Sites in Gab1. Biochemistry 43:12133\u201312140","journal-title":"Biochemistry"},{"key":"22_CR73","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/nature00904","volume":"418","author":"J. Lin","year":"2002","unstructured":"Lin J, Wu H, Tarr PT, et al. (2002) Transcriptional co-activator PGC-1\u03b1 drives the formation of slow-twitch muscle fibres. Nature 418:797\u2013801","journal-title":"Nature"},{"key":"22_CR74","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1097\/00004872-200305000-00011","volume":"21","author":"H. Lithell","year":"2003","unstructured":"Lithell H, Hansson L, Skoog I, et al. (2003) The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial. J Hypertens 21:875\u2013886","journal-title":"J Hypertens"},{"key":"22_CR75","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.2337\/diabetes.50.8.1844","volume":"50","author":"G. Marchesini","year":"2001","unstructured":"Marchesini G, Brizi M, Bianchi G, et al. (2001) Nonalcoholic fatty liver disease. A feature of the metabolic syndrome. Diabetes 50:1844\u20131850","journal-title":"Diabetes"},{"key":"22_CR76","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1172\/JCI17845","volume":"112","author":"H. Masuzaki","year":"2003","unstructured":"Masuzaki H, Yamamoto H, Kenyon CJ, et al. (2003) Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice. J Clin Invest 112:83\u201390","journal-title":"J Clin Invest"},{"key":"22_CR77","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.2337\/diabetes.51.6.1672","volume":"51","author":"M. Matsumoto","year":"2002","unstructured":"Matsumoto M, Ogawa W, Teshigawara K, et al. (2002) Role of the insulin receptor substrate 1 and phosphatidylinositol 3-kinase signaling pathway in insulin-induced expression of sterol regulatory element binding protein 1c and glucokinase genes in rat hepatocytes. Diabetes 51:1672\u20131680","journal-title":"Diabetes"},{"key":"22_CR78","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1172\/JCI200318816","volume":"112","author":"M. Matsumoto","year":"2003","unstructured":"Matsumoto M, Ogawa W, Akimoto K, et al. (2003) PKClambda in liver mediates insulin-induced SREBP-1c expression and determines both hepatic lipid content and overall insulin sensitivity. J Clin Invest 112:935\u2013944","journal-title":"J Clin Invest"},{"key":"22_CR79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2265.2002.01563.x","volume":"57","author":"F. Mauvais-Jarvis","year":"2002","unstructured":"Mauvais-Jarvis F, Kulkarni RN, Kahn CR (2002) Knockout models are useful tools to dissect the pathophysiology and genetics of insulin resistance. Clin Endocrinol 57:1\u20137","journal-title":"Clin Endocrinol"},{"key":"22_CR80","doi-asserted-by":"crossref","first-page":"797","DOI":"10.2337\/diabetes.51.3.797","volume":"51","author":"A.B. Mayerson","year":"2002","unstructured":"Mayerson AB, Hundal RS, Dufour S, et al. (2002) The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes. Diabetes 51:797\u2013802","journal-title":"Diabetes"},{"key":"22_CR81","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2337\/diabetes.51.1.7","volume":"51","author":"J.D. McGarry","year":"2002","unstructured":"McGarry JD (2002) Dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 51:7\u201318","journal-title":"Diabetes"},{"key":"22_CR82","doi-asserted-by":"crossref","first-page":"3820","DOI":"10.1073\/pnas.061035098","volume":"98","author":"L.F. Michael","year":"2001","unstructured":"Michael LF, Wu Z, Cheatham RB, et al. (2001) Restoration of insulin-sensitive glucose transporter (GLUT4) gene expression in muscle cells by the transcriptional coactivator PGC-1. Proc Natl Acad Sci USA 98:3820\u20133825","journal-title":"Proc Natl Acad Sci USA"},{"key":"22_CR83","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S1097-2765(05)00015-8","volume":"6","author":"M.D. Michael","year":"2000","unstructured":"Michael MD, Kulkarni RN, Postic C, et al. (2000) Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol Cell 6:87\u201397","journal-title":"Mol Cell"},{"key":"22_CR84","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0021-9150(03)00254-5","volume":"170","author":"G. Mingrone","year":"2003","unstructured":"Mingrone G, Rosa G, Greco AV, et al. (2003) Intramyocitic lipid accumulation and SREBP-1c expression related to insulin resistance and cardiovascular risk in morbid obesity. Atherosclerosis 170:155\u2013161","journal-title":"Atherosclerosis"},{"key":"22_CR85","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/414821a","volume":"414","author":"D.E. Moller","year":"2001","unstructured":"Moller DE (2001) New drug targets for type 2 diabetes and the metabolic syndrome. Nature 414:821\u2013827","journal-title":"Nature"},{"key":"22_CR86","doi-asserted-by":"publisher","first-page":"2707","DOI":"10.1210\/en.2003-1674","volume":"145","author":"N.M. Morton","year":"2004","unstructured":"Morton NM, Ramage L, Seckl JR (2004a) Down-regulation of adipose 11\u03b2-hydroxysteroid dehydrogenase type 1 by High-fat feeding in mice: a potential adaptive mechanism counteracting metabolic disease. Endocrinology 145:2707\u20132712","journal-title":"Endocrinology"},{"key":"22_CR87","doi-asserted-by":"crossref","first-page":"931","DOI":"10.2337\/diabetes.53.4.931","volume":"53","author":"N.M. Morton","year":"2004","unstructured":"Morton NM, Paterson JM, Mauzaki H, et al. (2004b) Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11 beta-hydroxysteroid dehydrogenase type 1-deficient mice. Diabetes 53:931\u2013938","journal-title":"Diabetes"},{"key":"22_CR88","first-page":"871","volume-title":"International textbook of diabetes mellitus","author":"S. Mudaliar","year":"2004","unstructured":"Mudaliar S, Henry RR (2004) Thiazolidiones as PPAR Agonists. In: DeFronzo RA, Ferrannini E, Keen H, Zimmet P (eds) International textbook of diabetes mellitus, 3rd Edn. John Wiley & Sons Ltd, Chichester, pp 871\u2013899","edition":"3rd Edn."},{"key":"22_CR89","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1749-6632.2002.tb04259.x","volume":"967","author":"D. M\u00fcller-Wieland","year":"2002","unstructured":"M\u00fcller-Wieland D, Kotzka J (2002) SREBP-1: gene regulatory key to Syndrome X? Ann NY Acad Sci 967:19\u201327","journal-title":"Ann NY Acad Sci"},{"key":"22_CR90","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1152\/physrev.00032.2003","volume":"84","author":"A. Nandi","year":"2004","unstructured":"Nandi A, Kitamura Y, Kahn CR, et al. (2004) Mouse models of insulin resistance. Physiol Rev 84:623\u2013647","journal-title":"Physiol Rev"},{"key":"22_CR91","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1073\/pnas.0308258100","volume":"101","author":"L. Orci","year":"2004","unstructured":"Orci L, Cook WS, Ravazzola M (2004) Rapid transformation of white adipocyte into fat-oxidizing machines. Proc Natl Acad Sci USA 101:2058\u20132063","journal-title":"Proc Natl Acad Sci USA"},{"key":"22_CR92","doi-asserted-by":"crossref","first-page":"7088","DOI":"10.1073\/pnas.0305524101","volume":"101","author":"J.M. Paterson","year":"2004","unstructured":"Paterson JM, Morteon NM, Fievet C, et al. (2004) Metabolic syndrome without obesity: Hepatic overexpression 11beta-hydroxysteroid dehydrogenase type 1 in transgenicmice. Proc Natl Acad Sci USA 101:7088\u20137093","journal-title":"Proc Natl Acad Sci USA"},{"key":"22_CR93","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0092-8674(03)01077-8","volume":"116","author":"R. Pawson","year":"2004","unstructured":"Pawson R (2004) Specificity in signal transduction: from phosphotyrosine-SH2 domain interactions to complex cellular systems. Cell 116:191\u2013203","journal-title":"Cell"},{"key":"22_CR94","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1056\/NEJMoa031314","volume":"350","author":"K.F. Petersen","year":"2004","unstructured":"Petersen KF, Dufour S, Befrey D, et al. (2004) Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 350:664\u2013671","journal-title":"N Engl J Med"},{"key":"22_CR95","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s00125-003-1313-3","volume":"47","author":"L. Pirola","year":"2004","unstructured":"Pirola L, Johnston AM, Van Obberghen E (2004) Modulation of insulin action. Diabetologia 47:170\u2013184","journal-title":"Diabetologia"},{"key":"22_CR96","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1177\/0091270004263018","volume":"44","author":"L.M. Prisant","year":"2004","unstructured":"Prisant LM (2004) Preventing type II diabetes mellitus. J Clin Pharmacol 44:406\u2013413","journal-title":"J Clin Pharmacol"},{"key":"22_CR97","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/S1097-2765(01)00390-2","volume":"8","author":"P. Puigserver","year":"2001","unstructured":"Puigserver P, Rhee J, Lin J, et al. (2001) Cytokine stimulation of energy expenditure through p38 MAP Ki activation of PPAR\u03b3 Coactivator-1. Mol Cell 8:971\u2013982","journal-title":"Mol Cell"},{"key":"22_CR98","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/nature01667","volume":"423","author":"P. Puigserver","year":"2003","unstructured":"Puigserver P, Rhee J, Donovan J, et al. (2003) Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction. Nature 423:550\u2013555","journal-title":"Nature"},{"key":"22_CR99","doi-asserted-by":"publisher","first-page":"36590","DOI":"10.1074\/jbc.M006287200","volume":"275","author":"S.A. Qureshi","year":"2000","unstructured":"Qureshi SA, Ding V, Li Z (2000) Activation of insulin signal transduction pathway and antidiabetic activity of small molecule insulin receptor activators. J Biol Chem 275:36590\u201336595","journal-title":"J Biol Chem"},{"key":"22_CR100","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s11883-003-0007-0","volume":"5","author":"G.M. Reaven","year":"2003","unstructured":"Reaven GM (2003) The insulin resistance syndrome. Curr Atherosclerosis Rep 5:365\u2013371","journal-title":"Curr Atherosclerosis Rep"},{"key":"22_CR101","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1101\/gad.14.11.1293","volume":"14","author":"E.D. Rosen","year":"2000","unstructured":"Rosen ED, Walkey CJ, Puigserver P, Spiegelman BM (2000) Transcriptional regulation of adipogenesis. Genes Dev 14:1293\u20131307","journal-title":"Genes Dev"},{"key":"22_CR102","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1101\/gad.948702","volume":"16","author":"E.D. Rosen","year":"2002","unstructured":"Rosen ED, Hsu CH, Wang X, et al. (2002) C\/EBPa induces adipogenesis through PPAR\u03b3: a unified pathway. Genes Dev 16:22\u201326","journal-title":"Genes Dev"},{"key":"22_CR103","doi-asserted-by":"publisher","first-page":"33302","DOI":"10.1074\/jbc.M005425200","volume":"275","author":"G. Roth","year":"2000","unstructured":"Roth G, Kotzka J, Kremer L, et al. (2000) MAP kinases Erk1\/2 phosphorylate sterol regulatory element-binding protein (SREBP)-1a at serine 117 in vitro. J Biol Chem 275:33302\u201333307","journal-title":"J Biol Chem"},{"key":"22_CR104","doi-asserted-by":"crossref","first-page":"42394","DOI":"10.1074\/jbc.C200444200","volume":"277","author":"L. Rui","year":"2002","unstructured":"Rui L, Yuan M, Frantz D, et al. (2002) SOCS-1 and SOCS-3 block insulin signalling by ubiquitin-mediated degradation of IRS1 and IRS2. J Biol Chem 277:42394\u201342398","journal-title":"J Biol Chem"},{"key":"22_CR105","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/414799a","volume":"414","author":"A.R. Saltiel","year":"2001","unstructured":"Saltiel AR, Kahn CR (2001) Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414:799\u2013806","journal-title":"Nature"},{"key":"22_CR106","doi-asserted-by":"publisher","first-page":"32345","DOI":"10.1074\/jbc.M313478200","volume":"279","author":"V.T. Samuel","year":"2004","unstructured":"Samuel VT, Liu ZX, Qu X, et al. (2004) Mechanism of Hepatic Insulin Resistance in Nonalcoholic Fat Liver Disease. J Biol Chem 279:32345\u201332353","journal-title":"J Biol Chem"},{"key":"22_CR107","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1651-2227.1996.tb14262.x","volume":"413","author":"M. Seip","year":"1996","unstructured":"Seip M, Trygstad O (1996) Generalized lipodystrophy, congenital and acquired (lipoatrophy). Acta Paediatr Suppl 413:2\u201328","journal-title":"Acta Paediatr Suppl"},{"key":"22_CR108","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s00125-003-1052-5","volume":"46","author":"E. Shafrir","year":"2003","unstructured":"Shafrir E, Raz I (2003) For Debate. Diabetes: mellitus or lipidus? Diabetologia 46:433\u2013440","journal-title":"Diabetologia"},{"key":"22_CR109","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1172\/JCI118951","volume":"98","author":"H. Shimano","year":"1996","unstructured":"Shimano H, Horton JD, Hammer RE, et al. (1996) Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a. J Clin Invest 98:1575\u20131584","journal-title":"J Clin Invest"},{"key":"22_CR110","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1172\/JCI119248","volume":"99","author":"H. Shimano","year":"1997","unstructured":"Shimano H, Horton JD, Shimomura I, et al. (1997) Isoform 1c of sterol regulatory element binding protein is less active than isoform1a in livers of transgenic mice and in cultured cells. J Clin Invest 99:846\u2013854","journal-title":"J Clin Invest"},{"key":"22_CR111","doi-asserted-by":"publisher","first-page":"43095","DOI":"10.1074\/jbc.M306880200","volume":"278","author":"S. Shimizu","year":"2003","unstructured":"Shimizu S, Ugi S, Maegawa H, et al. (2003) Protein-tyrosine phosphatase 1 as new activator for hepatic lipogenesis via sterol regulatory element-binding protein-1 gene expression. J Biol Chem 278:43095\u201343101","journal-title":"J Biol Chem"},{"key":"22_CR112","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1172\/JCI119247","volume":"99","author":"I. Shimomura","year":"1997","unstructured":"Shimomura I, Shimano H, Horton JD, et al. (1997) Differential expression of exons 1a and 1c in mRNAs for sterol regulatory element binding protein-1 in human and mouse organs and cultured cells. J Clin Invest 99:838\u2013845","journal-title":"J Clin Invest"},{"key":"22_CR113","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1101\/gad.12.20.3182","volume":"12","author":"I. Shimomura","year":"1998","unstructured":"Shimomura I, Hammer RE, Richardson JA, et al. (1998) Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy. Genes Dev 12:2182\u20133194","journal-title":"Genes Dev"},{"key":"22_CR114","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/43448","volume":"401","author":"I. Shimomura","year":"1999","unstructured":"Shimomura I, Hammer RE, Ikemoto S, et al. (1999) Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy. Nature 401:73\u201376","journal-title":"Nature"},{"key":"22_CR115","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1038\/sj.ijo.0802501","volume":"27","author":"S.E. Shoelson","year":"2003","unstructured":"Shoelson SE, Lee J, Yuan M (2003) Inflammation and the IKK\u00df\u03baB\/NF-\u03baB axis in obesity-and diet-induced insulin resistance. Int J Obesity 27:S49\u2013S52","journal-title":"Int J Obesity"},{"key":"22_CR116","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/dmrr.260","volume":"18","author":"S. Song","year":"2002","unstructured":"Song S (2002) The role of increased liver triglyceride content: a culprit of diabetic hypergly-caemia? Diabetes Metab Res Rev 18:5\u201312","journal-title":"Diabetes Metab Res Rev"},{"key":"22_CR117","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1210\/en.2004-0367","volume":"145","author":"A.M. Strack","year":"2004","unstructured":"Strack AM, Myers RW (2004) Modulation of metabolic syndrome by fibroblast growth factor 19 (FGF19)? Endocrinology 145:2591\u20132593","journal-title":"Endocrinology"},{"key":"22_CR118","doi-asserted-by":"publisher","first-page":"7128","DOI":"10.1074\/jbc.271.12.7128","volume":"271","author":"R. Streicher","year":"1996","unstructured":"Streicher R, Kotzka J, Muller-Wieland D, et al. (1996) SREBP-1 mediates activation of the low density lipoprotein receptor promoter by insulin and insulin-like growth factor-I. J Biol Chem 271:7128\u20137133","journal-title":"J Biol Chem"},{"key":"22_CR119","doi-asserted-by":"publisher","first-page":"25039","DOI":"10.1074\/jbc.M311956200","volume":"279","author":"R. Suzuki","year":"2004","unstructured":"Suzuki R, Tobe K, Aoyama M, et al. (2004) Both insulin signaling defects in the liver and obesity contribute to insulin resistance and cause diabetes in Irs2(-\/-) mice. J Biol Chem 279:25039\u201325049","journal-title":"J Biol Chem"},{"key":"22_CR120","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/372182a0","volume":"372","author":"H. Tamemoto","year":"1994","unstructured":"Tamemoto H, Kadowaki T, Tobe K, et al. (1994) Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature 372:182\u2013186","journal-title":"Nature"},{"key":"22_CR121","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1507\/endocrj.49.247","volume":"49","author":"Y. Terauchi","year":"2002","unstructured":"Terauchi Y, Kadowaki T (2002) Insights into molecular pathogenesis of type 2 diabetes from knockout mouse models. Endocr J 49:247\u2013263","journal-title":"Endocr J"},{"key":"22_CR122","doi-asserted-by":"crossref","first-page":"4753","DOI":"10.1128\/MCB.13.8.4753","volume":"13","author":"P. Tontonoz","year":"1993","unstructured":"Tontonoz P, Kim JB, Graves RA, Spiegelman BM (1993) ADD1: a novel helix-loop-helix transcription factor associated with adipocyte determination and differentiation. Mol Cell Biol 13:4753\u20134759","journal-title":"Mol Cell Biol"},{"key":"22_CR123","doi-asserted-by":"publisher","first-page":"5434","DOI":"10.1128\/MCB.24.12.5434-5446.2004","volume":"24","author":"K. Ueki","year":"2004","unstructured":"Ueki K, Kondo T, Kahn CR (2004) Suppressor of cytokine signalling 1 (SOCS-1) and SOCS-3 causes insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms. Mol Cell Biol 24:5434\u20135446","journal-title":"Mol Cell Biol"},{"key":"22_CR124","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/0092-8674(90)90801-K","volume":"20","author":"A. Ullrich","year":"1990","unstructured":"Ullrich A, Schlessinger J (1990) Signal transduction by receptors with tyrosine kinase activity. Cell 20:203\u2013212","journal-title":"Cell"},{"key":"22_CR125","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1146\/annurev.med.53.082901.104057","volume":"53","author":"R.H. Unger","year":"2002","unstructured":"Unger RH (2002) Lipotoxic diseases. Ann Rev Med 53:319\u2013336","journal-title":"Ann Rev Med"},{"key":"22_CR126","doi-asserted-by":"publisher","first-page":"5159","DOI":"10.1210\/en.2003-0870","volume":"144","author":"R.H. Unger","year":"2003","unstructured":"Unger RH (2003) Minireview: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome. Endocrinology 144:5159\u20135165","journal-title":"Endocrinology"},{"key":"22_CR127","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S1262-3636(07)70083-6","volume":"30","author":"B. Verg\u00e8s","year":"2004","unstructured":"Verg\u00e8s B (2004) Clinical interest of PPARs ligands. Particular benefit in type 2 diabetes and metabolic syndrome. Diabetes Metab 30:7\u201312","journal-title":"Diabetes Metab"},{"key":"22_CR128","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1517\/14728222.7.6.771","volume":"7","author":"B.R. Walker","year":"2003","unstructured":"Walker BR, Seckl RJ (2003) 11beta-hydroxysteroid dehydrogenase type 1 as a novel therapeutic target in metabolic and neurodegenerative diseases. Expert Opin Ther Targets 7:771\u2013783","journal-title":"Expert Opin Ther Targets"},{"key":"22_CR129","doi-asserted-by":"crossref","first-page":"14497","DOI":"10.1016\/S0021-9258(19)85266-3","volume":"268","author":"X. Wang","year":"1993","unstructured":"Wang X, Briggs MR, Hua X, Yokoyama C, Goldstein JL, Brown MS (1993) Nuclear protein that binds sterol regulatory element of low density lipoprotein receptor promoter. II. Purification and characterization. J Biol Chem 268:14497\u201314504","journal-title":"J Biol Chem"},{"key":"22_CR130","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1016\/S0140-6736(03)14364-4","volume":"362","author":"R. Weiss","year":"2003","unstructured":"Weiss R, Dufour S, Taksali SE, et al. (2003) Prediabetes in obese youth: a syndrome of impaired glucose tolerance, severe insulin resistance, and altered myocellular and abdominal fat partitioning. Lancet 362:1857\u20131858","journal-title":"Lancet"},{"key":"22_CR131","doi-asserted-by":"publisher","first-page":"35298","DOI":"10.1074\/jbc.M405203200","volume":"279","author":"E.D. Werner","year":"2004","unstructured":"Werner ED, Lee J, Hansen L, et al. (2004) Insulin resistance due to phosphorylation of insulin receptor substrate-1 at serine 302. J Biol Chem 279:35298\u201335305","journal-title":"J Biol Chem"},{"key":"22_CR132","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.bcp.2003.08.044","volume":"67","author":"K. Williams","year":"2004","unstructured":"Williams K, Rao YP, Natarajan R, et al. (2004) Indinavir alters sterol and fatty acid homeostatic mechanisms in primary rat hepatocytes by increasing levels of activated sterol regulatory element-binding proteins and decreasing cholesterol 7alpha-hydroxylase mRNA levels. Biochem Pharmacol 67:255\u2013267","journal-title":"Biochem Pharmacol"},{"key":"22_CR133","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1038\/36116","volume":"391","author":"D.J. Withers","year":"1998","unstructured":"Withers DJ, Gutierrez JS, Towery H, et al. (1998) Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391:900\u2013904","journal-title":"Nature"},{"key":"22_CR134","doi-asserted-by":"publisher","first-page":"5973","DOI":"10.1210\/jc.86.12.5973","volume":"86","author":"X. Wu","year":"2001","unstructured":"Wu X, Hoffstedt J, Deeb W, et al. (2001) Depot-specific variation in protein-tyrosine phosphatase activities in human omental and subcutaneous adipose tissue: a potential contribution to differential insulin sensitivity. J Clin Endocrinol Metab 86:5973\u20135980","journal-title":"J Clin Endocrinol Metab"},{"key":"22_CR135","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.1210\/jc.2003-032044","volume":"89","author":"A.H. Xiang","year":"2004","unstructured":"Xiang AH, Peters RK, Kjos SL, et al. (2004) Pharmacological treatment of insulin resistance at two different stages in the evolution of type 2 diabetes: impact of glucose tolerance and beta-cell function. J Clin Endocrinol Metab 89:2846\u20132851","journal-title":"J Clin Endocrinol Metab"},{"key":"22_CR136","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/0092-8674(93)90690-R","volume":"75","author":"C. Yokoyama","year":"1993","unstructured":"Yokoyama C, Wang X, Briggs MR, et al. (1993) SREBP-1, a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene. Cell 75:187\u2013197","journal-title":"Cell"},{"key":"22_CR137","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/35093050","volume":"413","author":"J.C. Yoon","year":"2001","unstructured":"Yoon JC, Puigserver P, Chen G, et al. (2001) Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature 413:131\u2013138","journal-title":"Nature"},{"key":"22_CR138","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1126\/science.1061620","volume":"293","author":"M. Yuan","year":"2001","unstructured":"Yuan M, Konstantopoulos N, Lee J, Hansen L, Li ZW, Karin M, Shoelson SE (2001) Reversal of obesity-and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science 293:1673\u20131677","journal-title":"Science"},{"key":"22_CR139","doi-asserted-by":"publisher","first-page":"24844","DOI":"10.1074\/jbc.M310688200","volume":"279","author":"J.M. Zabolotny","year":"2004","unstructured":"Zabolotny JM, Haj FG, Kim YB, et al. (2004) Transgenic overexpression of protein-tyrosine phosphatase 1B in muscle causes insulin resistance, but overexpression with leukocyte antigen-related phosphatase does not additively impair insulin action. J Biol Chem 279:24844\u201324851","journal-title":"J Biol Chem"},{"key":"22_CR140","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1126\/science.284.5416.974","volume":"284","author":"B. Zhang","year":"1999","unstructured":"Zhang B, Salituro G, Szalkowski D (1999) Discovery of a small molecule insulin mimetic with antidiabetic activity in mice. Science 284:974\u2013977","journal-title":"Science"},{"key":"22_CR141","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11883-002-0063-x","volume":"4","author":"O. Ziouzenkova","year":"2002","unstructured":"Ziouzenkova O, Perrey S, Marx N, et al. (2002) Peroxisome Proliferator-activated Receptors. Curr Atheroscler Rep 4:59\u201364","journal-title":"Curr Atheroscler Rep"}],"container-title":["Handbook of Experimental Pharmacology","Atherosclerosis: Diet and Drugs"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/3-540-27661-0_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T06:18:40Z","timestamp":1706681920000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/3-540-27661-0_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005]]},"ISBN":["9783540225690","9783540276616"],"references-count":141,"URL":"https:\/\/doi.org\/10.1007\/3-540-27661-0_22","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/3-540-27661-0","asserted-by":"object"}]},"ISSN":["0171-2004"],"issn-type":[{"value":"0171-2004","type":"print"}],"subject":[],"published":{"date-parts":[[2005]]}}}